#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital absence of bile ducts Factor IX deficiency Malignant neoplasm of choroid Marginal zone lymphoma refractory Mucopolysaccharidosis III Meningococcal immunisation Small intestine adenocarcinoma Mucopolysaccharidosis I Erythema Essential thrombocythaemia Fatty acid oxidation disorder Anal cancer Frontotemporal dementia Anal squamous cell carcinoma Neuropathy peripheral More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Treatment Optic glioma – Life with Disease Mucopolysaccharidosis I – Treatment KBG syndrome – Trials in Disease Mastocytosis – Life with Disease Crigler-Najjar syndrome – Basic Information Hairy cell leukaemia – Life with Disease Fabry’s disease – Treatment Sjogren’s syndrome – Basic Information Ewing’s sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acou085 Trametinib Dimethyl Sulfoxide HSP-CAR19M RUBIDIUM CHLORIDE Cefalexin Tucatinib Axitinib SEVABERTINIB Oditrasertib Hct116-A AMO959 Tetracycline Hydrochloride Triamcinolone Leuprorelin ALXN1920 Litifilimab Calcium Chloride Dihydrate Apalutamide GVV858 Pralatrexate More therapies…

    Learn about Your Condition

    Craniotomy Cervix carcinoma stage III Rhabdoid tumour Atrial flutter Lung disorder Acute HIV infection Indolent systemic mastocytosis Progressive supranuclear palsy Malignant oligodendroglioma Nocturia Graft versus host disease Rosai-Dorfman syndrome Lymphoedema Hidradenitis Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    France Greece Spain

  • Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France

  • Study of Metronomic Oral Vinorelbine with Durvalumab and Tremelimumab for Patients with Advanced Solid Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Durvalumab
    France

  • Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Alveolar proteinosis
    Investigated Drugs:
    • Molgramostim
    Belgium France Germany Ireland Italy Poland +3

  • Study on Guselkumab for Healing in Crohn’s Disease Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Guselkumab
    Belgium Czechia France Germany Italy Poland +2

  • Study on Clebopride for Treating Rumination Syndrome in Patients Suspected of Having the Condition

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Merycism
    Investigated Drugs:
    • Clebopride Hydrogen Maleate
    Belgium
Previous Page
1 … 1,674 1,675 1,676 1,677 1,678 … 1,695
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!